Subscribe to our updates:



 Today on the Hill Health Policy Report Financial Services Report

Subscribe
 

 
 

Redefining the art of advocacy.

Thorn Run Partners is not just another lobbying firm. We have been called "nimble," "new generation," and "rabidly bipartisan." While our firm boasts all the expertise and government credentials of Washington's mega-firms, we also bring the creativity, collaboration and discipline of an elite boutique. And in a business where measurable progress is often in short supply, we pride ourselves on delivering real results for our clients.

Bulletin Board

Latest update from the TRP Blog

Today on the Hill: Senate Goes into Overtime on Spending Bill

Yesterday, the House successfully passed both a continuing resolution (CR) (H.R. 2028) funding the government through April 28 and a water projects bill (S. 612) that would provide resources to Flint, Michigan to help clean its lead-tainted water supply. The bills face a steeper hurdle in the Senate, however, as Democrats dig in their heels over a miners’ health plan provision in the spending measure and a California water diversion plan in the water projects legislation. Considering both bills were approved in the House on a broad bipartisan basis – 326-96 for the spending measure and 360-61 for the water resources bill – it remains to be seen if the obstructing senators will have a politically-viable argument to delay the bills’ passage.

Featured Post

Selected article from the TRP Blog

What We Know About ACA Repeal & Replace

After six years of campaigning to repeal the Affordable Care Act (ACA) and over 50 votes held to undercut the law, Republicans in Congress will be ‘shooting with real bullets’ in the 115th Congress – thanks in part to the election of Donald Trump – and will finally be positioned to deliver on their long-held position that President Obama’s healthcare law should be repealed as expeditiously as possible. But without a concrete replacement plan in place, Republicans remain at a crossroads over what set of policies should encompass their ACA alternative, and face the politically challenging prospect of deciding how – and how quickly – they will be able to achieve consensus.